Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC Cancer 2015, 15, 415. [CrossRef] [PubMed]Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A...
borderline tumor Surgical pathology A term used for neoplasms with many histologic criteria of malignancy, for which the future behavior is uncertain. SeeStump. McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc. ...
The OR for borderline ovarian cancer among treated nulliparous women compared with untreated infertile nulliparous women was 1.5, and the OR among treated parous women compared with untreated infertile parous women was 1.5. Conclusion(s): Among fertile women, the difference in the risk of borderline...
Table 6 Pathoclinical features of patients with stage I borderline ovarian tumor from Zhejiang Cancer Hospital Full size table Discussion With a sample size of 2946 patients and a median follow-up time of 200 months, this study examined age-specific impact of fertility preserving surgery on disease...
Here we report the outcomes of 26 patients who relapsed following conservative surgical treatment of stage I serous borderline ovarian tumours treated init... U Catherine,M Eve,K Aminata,... - 《Human Reproduction》 被引量: 17发表: 2013年 认识和掌握交界性病变/肿瘤 (precancerous lesion),恶性...
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC Cancer 2015; 15: 415.Mackenzie, R.; Kommoss, S.; Winterhoff, B.J.; Kipp, B.R.; Garcia, J.J.; Voss, J.; Halling, K.; Karnezis,...
OVARIAN tumorsPRECANCEROUS conditionsFISHER exact testRETROSPECTIVE studiesCYTOREDUCTIVE surgeryDESCRIPTIVE statisticsIMMUNOHISTOCHEMISTRYMEDICAL recordsSimple Summary: Ovarian serous borderline tumor (SBT) is a known precursor of low-grade serous carcinoma, and it has been reported that about 50% of SBTs are...
ovarian cancer;high-grade serous carcinoma;low-grade serous carcinoma;serous borderline tumor;MDM2 1. Introduction Ovarian cancer is the leading cause of death among Japanese females diagnosed with gynecological cancers [1]. According to the World Health Organization (WHO) Classification of tumors of ...
In 1971, the International Federation of Obstetrics and Gynecology (FIGO) identified these “semimalignant” ovarian tumors as a “low-grade malignant tumor” totally different from ovarian cancer, and the word “borderline tumor” displaced “low-grade malignant tumor” in the World Health ...